CYRIL MANGEOT – Trademark Portfolio

Entity Type: 98

CYRIL MANGEOT holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 5 Nice Classification classes.

139 Bd Fanfarigoule

F-06210 Mandelieu-La-Napoule

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CYRIL MANGEOT's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CYRIL MANGEOT have?

CYRIL MANGEOT has 2 U.S. trademarks filed with the USPTO.

What trademark classes does CYRIL MANGEOT file in?

CYRIL MANGEOT files trademarks across 5 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What is CYRIL MANGEOT's trademark registration success rate?

CYRIL MANGEOT has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.